EMEA-001828-PIP01-15-M02
Key facts
| Active substance |
Pegunigalsidase alfa
|
| Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
| Decision number |
P/0193/2021
|
| PIP number |
EMEA-001828-PIP01-15-M02
|
| Pharmaceutical form(s) |
Solution for infusion
|
| Condition(s) / indication(s) |
Treatment of Fabry disease
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Chiesi Farmaceutici S.p.A.
E-mail: m.toschi@chiesi.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|